Cape Investment Advisory’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.9K Buy
+1,722
New +$38.7K 0.01% 562
2026
Q1
Sell
-596
Closed -$14.2K 554
2025
Q4
$14.2K Buy
596
+157
+36% +$3.9K ﹤0.01% 679
2025
Q3
$11.6K Buy
439
+111
+34% +$2.85K 0.01% 381
2025
Q2
$9.37K Buy
328
+90
+38% +$2.42K ﹤0.01% 646
2025
Q1
$5.93K Sell
238
-75
-24% -$1.79K ﹤0.01% 711
2024
Q4
$7.09K Hold
313
﹤0.01% 658
2024
Q3
$6.67K Hold
313
﹤0.01% 638
2024
Q2
$5.97K Hold
313
﹤0.01% 624
2024
Q1
$6.04K Buy
313
+224
+252% +$4.44K ﹤0.01% 623
2023
Q4
$1.85K Hold
89
﹤0.01% 936
2023
Q3
$1.92K Hold
89
﹤0.01% 790
2023
Q2
$2.13K Buy
89
+26
+41% +$596 ﹤0.01% 766
2023
Q1
$1.34K Buy
+63
New +$1.21K ﹤0.01% 856

Other funds holding FMS

Cape Investment Advisory's FMS Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in Fresenius Medical Care (FMS) in Q2 2026: 1,722 shares worth $38.9K. The stake represents 0.01% of the portfolio and ranks #562 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in FMS as recently as Q4 2025.

Cape Investment Advisory first reported a position in FMS in Q1 2023 and has held it in 13 quarters since. 233 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Cape Investment Advisory held 1,722 shares of Fresenius Medical Care worth $38.9K as of Q2 2026.
  • Fresenius Medical Care was a new Cape Investment Advisory position in Q2 2026.
  • Fresenius Medical Care made up 0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #562 holding.
  • Cape Investment Advisory first reported a position in Fresenius Medical Care in Q1 2023 and has held it in 13 quarters since.
  • 233 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.